ATEX vs SRPT · P/E 16, rev $6.5M vs rev $1.13B
Anterix Inc (ATEX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Anterix Inc (ATEX) is a telecom services company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ATEX revenue for 2026-03-31 was $6.5M. Net income was $90.6M. Revenue was up 7.8% from 2025-03-31 to 2026-03-31. ATEX currently screens at market cap $1.50B and trailing P/E 16.4.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
ATEX currently screens at market cap $1.50B and trailing P/E 16.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ATEX and SRPT stock pages for the full models.
Not investment advice.